Table 1.
No T2DM or DEP (n = 2256) |
DEP Only (n = 51) |
T2DM Only (n = 685) |
T2DM + DEP (n = 17) |
Total Sample (n = 3009) |
pa | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | 73.6 | (2.9) | 73.4 | (2.9) | 73.7 | (2.8) | 74.0 | (3.3) | 73.6 | (2.9) | 0.88† |
Gender | <.001 | ||||||||||
Men | 1058 | [46.9] | 17 | [33.3] | 379 | [55.3] | 7 | [41.2] | 1461 | [48.6] | |
Women | 1198 | [53.1] | 34 | [66.7] | 306 | [44.7] | 10 | [58.8] | 1548 | [51.5] | |
Ethnicity | <.001 | ||||||||||
White | 1393 | [61.8] | 38 | [74.5] | 328 | [47.9] | 8 | [47.1] | 1767 | [58.7] | |
Black | 863 | [38.3] | 13 | [25.5] | 357 | [52.1] | 9 | [52.9] | 1242 | [41.3] | |
Site | 0.17 | ||||||||||
Memphis | 1125 | [49.9] | 25 | [49.0] | 349 | [51.0] | 4 | [23.5] | 1503 | [50.0] | |
Pittsburgh | 1131 | [50.1] | 26 | [51.0] | 336 | [49.1] | 13 | [76.5] | 1506 | [50.1] | |
Education | <.001 | ||||||||||
Less than H.S. | 484 | [21.5] | 9 | [17.7] | 210 | [30.8] | 6 | [35.3] | 709 | [23.6] | |
H.S. | 618 | [27.5] | 21 | [41.2] | 183 | [26.8] | 8 | [47.1] | 830 | [27.7] | |
Trade/Vocational | 141 | [6.3] | 5 | [9.8] | 48 | [7.0] | 2 | [11.8] | 196 | [6.5] | |
Part College | 424 | [18.8] | 8 | [15.7] | 109 | [16.0] | 1 | [5.9] | 542 | [18.1] | |
College | 307 | [13.6] | 7 | [13.7] | 67 | [9.8] | ------ | 381 | [12.7] | ||
Post-College | 276 | [12.3] | 1 | [2.0] | 65 | [9.5] | ------ | 342 | [11.4] | ||
Current Smoker | 242 | [10.7] | 7 | [13.7] | 56 | [8.2] | 4 | [23.5] | 309 | [10.3] | <.01 |
Total Body Fat (Kg) | 35.0 | (7.9) | 37.5 | (7.1) | 35.0 | (7.6) | 34.2 | (8.7) | 35.0 | (7.8) | 0.15† |
Triglycerides | 131.5 | (75.4) | 140.7 | (72.8) | 161.9 | (100.3) | 158.5 | (96.2) | 138.8 | (82.8) | <.001† |
Lung Disease | 243 | [10.8] | 11 | [21.6] | 91 | [13.3] | ------ | 345 | [11.5] | <.05 | |
Heart Disease | 560 | [24.8] | 15 | [29.4] | 253 | [36.9] | 6 | [35.3] | 834 | [27.7] | <.001 |
Anti-inflammatory drugs | 1195 | [53.0] | 32 | [62.8] | 359 | [52.5] | 10 | [58.8] | 1596 | [53.1] | 0.53 |
Antidepressant drugs | 60 | [2.7] | 8 | [15.7] | 5 | [0.7] | 3 | [17.7] | 76 | [2.5] | <.001 |
Rheumatoid Arthritis | 140 | [20.7] | 5 | [26.3] | 53 | [27.6] | 1 | [16.7] | 199 | [22.2] | 0.22 |
Statins | 279 | [12.4] | 6 | [11.8] | 104 | [15.2] | 1 | [5.9] | 390 | [13.0] | 0.21 |
CES-D | 4.2 | (4.3) | 24.7 | (5.1) | 4.2 | (4.2) | 27.4 | (5.7) | 4.7 | (5.3) | <.001† |
HbA1c | ------ | ------ | 7.6 | (1.6) | 7.5 | (1.5) | 7.6 | (1.6) | 0.79‡ | ||
Insulin Use | ------ | ------ | 116 | [26.9] | 4 | [36.4] | 120 | [17.1] | 0.65 | ||
Diabetes Duration | ------ | ------ | 13.0 | (10.7) | 14.1 | (12.7) | 13.1 | (10.7) | 0.75‡ | ||
Oral Hypoglycemic Agents | ------ | ------ | 256 | [59.5] | 7 | [63.6] | 263 | [37.5] | 0.81 | ||
Acute Respiratory Infection | 132 | [6.3] | 2 | [4.4] | 45 | [7.1] | 3 | [18.8] | 182 | [6.5] | 0.18 |
Data presented as mean (SD) or n [%].
p-values are based on χ2 tests for categorical variables and
ANOVA and
t test for continuous variables.